China is investigating PwC's dealings with Evergrande, signaling increased scrutiny over the financial practices of one of the world's largest real estate developers. Concurrently, China's top trade official has extended an invitation to Eli Lilly, urging the pharmaceutical giant to expand its investments within the country. This move comes as part of a broader effort to attract international pharmaceutical companies, despite the United States' efforts to sever such ties. Additionally, tensions have escalated due to China's territorial assertions, with recent actions being labeled as a strategic disaster.